Abstract
Extracellular ATP and its metabolites affect various cellular immune responses, including T cell function, but there are apparently conflicting reports concerning the effects of adenine nucleotides on T cells. For example, it has been reported that ATP-mediated activation of P2 receptor is involved in T cell activation; activation of adenosine receptors suppresses T cell function; and 1 mM ATP induces T cell death via activation of P2X7 receptor. Therefore, in this work we investigated in detail the effects of 100–250 μM ATP, ADP, or AMP on murine T cell activation. First, an in vitro study showed that pretreatment of murine splenic T cells with 100–250 μM ATP, ADP, or AMP significantly suppressed the concanavalin A (ConA)-induced release of cytokines, including IL-2. This suppression was not due to induction of cell death via the P2X7 receptor or to an immunosuppressive effect of adenosine. ATP attenuated the expression of CD25, and decreased the cell proliferation ability of activated T cells. The release of IL-2 by ConA-stimulated lymphocytes was suppressed by post-treatment with ATP, as well as by pretreatment. These results suggest that exogenous ATP suppresses the activation of T cells. Secondly, we evaluated the effect of ATP in a ConA-treated mice. Treatment with ATP attenuated the increase of IL-2 concentration in the blood. Overall, these results suggest that adenine nucleotides might have potential as supplemental therapeutic agents for T cell-mediated immune diseases, by suppressing T cell activation.
Highlights
Activation of T cells by mitogen-activated protein kinase (MAPK) induces various responses necessary for immune function
Previous studies have demonstrated that P2X, P2Y, and adenosine receptors play roles in both T cell receptor (TCR) stimulation-induced and hypertonic stress-induced T cell activation (Yip et al, 2007; Woehrle et al, 2010)
We found that production of IL-2, an inflammatory cytokine, in splenocytes of BALB/c mice was increased dose-dependently by Concanavalin A (ConA), and was maximum at
Summary
Activation of T cells by MAPKs induces various responses necessary for immune function. There are three major MAPK pathways that operate in T-cells (Rincon et al, 2000a,b; Gong et al, 2001), involving c-Jun NH2-terminal kinase, extracellular signal regulatory protein kinase (ERK) (Fischer et al, 2005; Zhang and Dong, 2005), and p38 MAPK. Activation of these MAPKs results in nuclear translocation and promoter binding of transcription factors, and results in gene expression of a number of mediators involved in the inflammatory response (Marshall et al, 1995; Whitehurst and Geppert, 1996). Elevated intracellular Ca2+ ion concentration is essential for T cell activation.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
